The mortality rate for autoimmune hepatitis varies depending on the severity of the condition, as well as the length of time it has been present and the presence of any other complications. Generally, the mortality rate for autoimmune hepatitis is estimated to be between 5%-15% over a 10-year period. This means that, on average, between 5%-15% of patients with autoimmune hepatitis will die over a 10-year period.
The mortality rate is higher in those with more severe forms of the condition, and those with a longer duration of the disease. In some cases, the mortality rate can be as high as 30-50% over a 10-year period. It is important to note that these higher mortality rates are typically seen in patients who do not receive adequate treatment and monitoring for their condition.
Complications of autoimmune hepatitis can also increase the mortality rate, as they can cause the condition to worsen and become more serious. Complications such as liver cirrhosis, liver failure, and liver cancer can all significantly increase the risk of death for those with autoimmune hepatitis.
Overall, the mortality rate for autoimmune hepatitis is estimated to be between 5%-15% over a 10-year period. However, this rate can be significantly higher in those with more severe forms of the condition, and those with a longer duration of the disease, or who have developed complications. It is important to receive appropriate treatment and monitoring to reduce the risk of mortality associated with autoimmune hepatitis.